AmerisourceBergen Coughs Up $625M to Resolve U.S. Government Probe Post author:Sam Post published:November 21, 2017 Post category:BioPharma The agreement, whose final terms are still being negotiated, must be approved by a court. Source: BioSpace You Might Also Like AbbVie's PARP Inhibitor Fails to Deliver in Two Late-Stage Studies April 19, 2017 3 Bioeconomy Stocks Investors Should Not Hesitate to Buy November 29, 2017 Deal Spree Continues as Celgene Nabs Juno in $9B Deal January 21, 2018